Alan M. Garber, MD, PhD
Provost of Harvard University, Mallinckrodt Professor of Health Care Policy at Harvard Medical School and a Professor of Economics in the Harvard Kennedy School of Government and the Faculty of Arts and Sciences and Former Stanford Health Policy Director; Henry J. Kaiser, Jr. Professor EmeritusView Alan Garber's bio, list of research, recent publications and events »
The following is a collection of news items with mention of Alan Garber found on various external websites using an automated process:
July 12th, 2011
Individualized cost-effectiveness analysis useful for clinicians and patients
Mention of Alan Garber via EurekAlert (press release)John Ioannidis and Alan Garber from Stanford University, USA, discuss how to use incremental cost-effectiveness ratios (ICER) and related metrics so they can be useful for decision-making at the individual level, whether used by clinicians or individual patients. The authors say that "Cost-effectiveness analysis offers a foundation for rational decision-making and can be very helpful in making health care more efficient and effective at the population level.
Read more »
April 18th, 2011
Stanford's Garber assumes role of Harvard provost
Mention of Alan Garber via The Stanford DailyProfessor of Medicine Alan Garber MD '83 will sport crimson rather than cardinal this fall as he takes on the role of provost at Harvard University in Cambridge, Mass. In his 25 years at Stanford, Garber has distinguished himself beyond the medical ...
Read more »
April 15th, 2011
Harvard Names Alan Garber of Stanford as Its Next Provost
Mention of Alan Garber via BloombergHarvard University named Alan Garber, a Stanford University professor of medicine and economics, as its next provost, replacing Steven Hyman, who will step down at the end of the academic year.
Read more »
November 8th, 2010
Cancer-vaccine review highlights debate over costs and benefits of pricey ...
Mention of Alan Garber via Scope (blog)(The drug, which was developed at Stanford, was the first-ever cancer vaccine to get the FDA's nod.) Now, the federal government has launched what is being ...
Read more »
November 1st, 2010
New drug may provide more cost-effective stroke prevention than warfarin ...
Mention of Alan Garber via EurekAlert (press release)STANFORD, Calif. — A newly approved drug may be a cost-effective way to prevent stroke in patients with an irregular heart rhythm — and may also offer ...
Read more »



About CISAC
Mailing List
@StanfordCISAC
Facebook